Adnan Khalid, MD
Cardiologist

Dr. Adnan Khalid joined ACS in 2019.

Adnan Khalid, MD

Dr. Adnan Khalid joined ACS in 2019.

Education
  • Interventional Cardiology – Fellowship
    University of Missouri at Kansas City, Mid America Heart Institute July 2013 – June 2014

  • Heart Failure/Transplant – Fellowship
    University of Missouri at Kansas City, Mid America Heart Institute July 2012 – June 2013

  • Cardiology – Fellowship
    University of Missouri at Kansas City, Mid America Heart Institute July 2009 – June 2012

  • Chief Residency
    Chief of house staff physician at University of Missouri at Kansas City October 2008- June 2009

  • Residency
    House Staff Physician: Department of Internal Medicine at University of Missouri at Kansas City 2005 – 2008

  • Medical School
    Nishtar Medical College (NMC) Multan, Pakistan 1997-2002

Board Certifications
  • 2016 American Board Of Internal Medicine, Heart Failure/Transplant Cardiology
  • 2014 American Board of Internal Medicine, Interventional Cardiology
  • 2012 American Society of Echocardiography
  • 2012 American Board of Internal Medicine, Cardiovascular Disease
  • 2008 American Board of Internal Medicine

Affiliations

  • American College of Cardiology July 2009- present.
  • American heart Association.
  • American Medical association (AMA)
  • American College of Physicians associate member from 2004-2007
  • Trans catheter Cardiovascular Therapies society
  • International Society of Heart and Lung Transplantation
Research
  • Paul S. Chan, Adnan Khalid, Lance S. Longmore, Robert A. Berg, Mikhail Kosiborod, John A. Spertus: Hospital-wide Code Rates and Mortality Before and After Implementation of a Rapid Response Team: JAMA, December 3, 2008; 300: 2506 – 2513. AHA Scientific session in November 2008 Circulation, Oct 2008; 118: S 307.
  • Mikhail Kosiborod, Silvio Inzucchi, Mitchell Hamburg, Lisa Riggs, Sindhu Koshy, Harlan M Krumholz, Lan Xiao, Adnan Khalid, and John A Spertus: Feasibility, Effectiveness and Safety Of Intensive Glucose Control in Critically Ill Hyperglycemic Patients Hospitalized With Acute Coronary Syndromes: AHA scientific session in November 2007 Circulation, Oct 2007; 116: II 799.
  • Cournand and Comroe Young Investigator Prize in Cardiopulmonary and Critical Care
    Paul S. Chan, Adnan Khalid, Lance Longmore, Mid-America Heart Institute, Kansas City, MO; Robert Berg, Univ of Arizona at Tucson, Tucson, AZ, Mary Ann Peberdy, Virginia Commonwealth Univ, Charlottesville, VA, Mikhail Kosiborod, John A. Spertus: Long-Term Effects of a Rapid Response Team on Hospital-Wide Code Rates and Mortality: AHA Scientific session in November 2008 Finalist; Abstract 502
  • Lisa L. Kusnetzky, Adnan Khalid, Taiyeb M. Khumri, Tabitha G. Moe, Philip G. Jones, and Michael L. Main: Acute Mortality in Hospitalized Patients Undergoing Echocardiography With and Without an Ultrasound Contrast Agent Results in 18,671 Consecutive Studies: J. Am. Coll. Cardiol. April 29, 2008; 51: 1704 – 1706.
  • Aamir Cheema, Adnan Khalid, Alan Wimmer, Cheryl Bartone, Theodore Chow, John A Spertus, Paul Chan: Fragmented QRS and Mortality Risk in Patients with Left Ventricular Dysfunction: Circ Arrhythm Electrophysiol. 2010 Aug 1; 3(4): 339-44
  • Adnan Khalid MD and Steven P Marso MD: IVUS With Virtual Histology In Clinical Practice Today: May/June 2011 Cardiac Interventions Today
  • Adnan Khalid, Salman K Bhatti, Mohammad Al-Amoodi, James H O’Keefe, Michael L Main Clinical Factors Associated with Left Ventricular Ejection Fraction Disparity in Patients With Left Ventricular Dysfunction Undergoing Multimodality Imaging: Missouri Medicine 2012, 109(6): 489-492
  • Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial remodeling and Outcomes (PROVE-HF) Primary Investigator Adnan Khalid from Nebraska Heart Institute
  • Prospective ARNI VS ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events After MI (PARADISE-MI) Primary Investigator Adnan Khalid from Nebraska Heart Institute
  • Study to Evaluate the Effect of Dapagliflozin on the incidence of Worsening Heart Failure or Cardiovascular Death in Patients with Chronic Heart Failure (DAPA-HF) Sub Primary Investigator Adnan Khalid from Nebraska Heart Institute